Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: the Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10)

被引:3
作者
Kamiya, Hideki [1 ]
Himeno, Tatsuhito [1 ,2 ]
Watarai, Atsuko [3 ]
Baba, Masayuki [4 ]
Nishimura, Rimei [5 ]
Tajima, Naoko [6 ]
Nakamura, Jiro [1 ,2 ]
机构
[1] Aichi Med Univ, Sch Med, Dept Internal Med, Div Diabet, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan
[2] Aichi Med Univ, Sch Med, Dept Innovat Diabet Therapy, Nagakute, Japan
[3] Meijo Hosp, Dept Gastroenterol & Hepatol, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Nagoya, Japan
[4] Aomori Prefectural Cent Hosp, Dept Neurol, Aomori, Japan
[5] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan
[6] Jikei Univ, Sch Med, Tokyo, Japan
关键词
JDCP study; Diabetic symmetric sensorimotor polyneuropathy; The simple diagnostic criteria for diabetic polyneuropathy; Prevalence; PERIPHERAL NEUROPATHY; DIAGNOSTIC-CRITERIA; DEFICIENCY; EXERCISE; ASSOCIATION; THERAPY;
D O I
10.1007/s13340-023-00678-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim/introductionThis study aims to investigate the prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy (DSPN) in patients with type 2 diabetes registered in the Japan Diabetes Complication and its Prevention Prospective (JDCP) study.Materials and methodsIn the study, 6338 patients with diabetes who had been treated by diabetes specialists were registered in 2007-2009. Of these, patients with type 2 diabetes who could be evaluated for DSPN were analyzed using t test, chi-square test, and logistic regression analyses. DSPN was diagnosed using the Simple Diagnostic Criteria for Diabetic Polyneuropathy proposed by the Diabetic Neuropathy Study Group in Japan.ResultsOf the total participants, 5451 patients (mean age 61.4 years old and duration of diabetes 10.8 years) were analyzed. Based on the criteria, 35.8% of patients were diagnosed with DSPN. The prevalence of sensory symptoms was 25.8%. The following factors increased risk for DSPN: age [odds ratio (OR) 1.57, 95% confidence intervals (CI) 1.42-1.73], duration of diabetes (OR 1.32, 95% CI 1.21-1.43), body mass index (OR 1.19, 95% CI 1.09-1.30), systolic blood pressure (OR 1.06, 95% CI 1.01-1.10), hemoglobin A1c (OR 1.15, 95% CI 1.09-1.22), biguanides (OR 1.22, 95% CI 1.06-1.39), and insulin therapy (OR 1.59, 95% CI 1.36-1.84). The following factors decreased risk for DSPN: total cholesterol (OR 0.98, 95% CI 0.96-1.00) and exercise therapy (OR 0.85, 95% CI 0.73-0.98).ConclusionsThe baseline survey clarified the prevalence and characteristics of DSPN in Japanese patients with type 2 diabetes. The survey also revealed the risk factors of DSPN.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 30 条
[1]   NIS-LL: The primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy [J].
Bril, V .
EUROPEAN NEUROLOGY, 1999, 41 :8-13
[2]   Neuroprotective Effects of Exercise Treatments After Injury: The Dual Role of Neurotrophic Factors [J].
Cobianchi, Stefano ;
Arbat-Plana, Ariadna ;
Lopez-Alvarez, Victor M. ;
Navarro, Xavier .
CURRENT NEUROPHARMACOLOGY, 2017, 15 (04) :495-518
[3]  
de Groot-Kamphuis DM, 2013, NETH J MED, V71, P386
[4]   A PRACTICAL 2-STEP QUANTITATIVE CLINICAL AND ELECTROPHYSIOLOGICAL ASSESSMENT FOR THE DIAGNOSIS AND STAGING OF DIABETIC NEUROPATHY [J].
FELDMAN, EL ;
STEVENS, MJ ;
THOMAS, PK ;
BROWN, MB ;
CANAL, N ;
GREENE, DA .
DIABETES CARE, 1994, 17 (11) :1281-1289
[5]   MUSCLE-DERIVED NEUROTROPHIN-4 AS AN ACTIVITY-DEPENDENT TROPHIC SIGNAL FOR ADULT MOTOR-NEURONS [J].
FUNAKOSHI, H ;
BELLUARDO, N ;
ARENAS, E ;
YAMAMOTO, Y ;
CASABONA, A ;
PERSSON, H ;
IBANEZ, CF .
SCIENCE, 1995, 268 (5216) :1495-1499
[6]   Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directions [J].
Himeno, Tatsuhito ;
Kamiya, Hideki ;
Nakamura, Jiro .
JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (01) :5-16
[7]   Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy [J].
Hotta, N. ;
Kawamori, R. ;
Fukuda, M. ;
Shigeta, Y. .
DIABETIC MEDICINE, 2012, 29 (12) :1529-1533
[8]   A large-scale observational study to investigate the current status of diabetic complications and their prevention in Japan (JDCP study 6): baseline dental and oral findings [J].
Inagaki, Koji ;
Kikuchi, Takeshi ;
Noguchi, Toshihide ;
Mitani, Akio ;
Naruse, Keiko ;
Matsubara, Tatsuaki ;
Kawanami, Masamitsu ;
Negishi, Jun ;
Furuichi, Yasushi ;
Nemoto, Eiji ;
Yamada, Satoru ;
Yoshie, Hiromasa ;
Tabeta, Koichi ;
Tomita, Sachiyo ;
Saito, Atsushi ;
Katagiri, Sayaka ;
Izumi, Yuichi ;
Nitta, Hiroshi ;
Iwata, Takanori ;
Numabe, Yukihiro ;
Yamamoto, Matsuo ;
Yoshinari, Nobuo ;
Fujita, Tsuyoshi ;
Kurihara, Hidemi ;
Nishimura, Fusanori ;
Nagata, Toshihiko ;
Yumoto, Hiromichi ;
Naito, Toru ;
Noguchi, Kazuyuki ;
Ito, Koichi ;
Murakami, Shinya ;
Nishimura, Rimei ;
Tajima, Naoko .
DIABETOLOGY INTERNATIONAL, 2021, 12 (01) :52-61
[9]   Long-term metformin therapy and vitamin B12 deficiency: An association to bear in mind [J].
Infante, Marco ;
Leoni, Martina ;
Caprio, Massimiliano ;
Fabbri, Andrea .
WORLD JOURNAL OF DIABETES, 2021, 12 (07) :916-931
[10]   Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial [J].
Ismail-Beigi, Faramarz ;
Craven, Timothy ;
Banerji, Mary Ann ;
Basile, Jan ;
Calles, Jorge ;
Cohen, Robert M. ;
Cuddihy, Robert ;
Cushman, William C. ;
Genuth, Saul ;
Grimm, Richard H., Jr. ;
Hamilton, Bruce P. ;
Hoogwerf, Byron ;
Karl, Diane ;
Katz, Lois ;
Krikorian, Armand ;
O'Connor, Patrick ;
Pop-Busui, Rodica ;
Schubart, Ulrich ;
Simmons, Debra ;
Taylor, Harris ;
Thomas, Abraham ;
Weiss, Daniel ;
Hramiak, Irene .
LANCET, 2010, 376 (9739) :419-430